Valneva

Valneva is a specialty vaccine company with a focus on developing, manufacturing, and commercializing prophylactic vaccines for infectious diseases that address unmet medical needs. Their vision is to contribute to a world where no one dies or suffers from a vaccine-preventable disease. Valneva has successfully commercialized three vaccines, including the world's first and only chikungunya vaccine, and is rapidly advancing a broad range of vaccine candidates into and through clinical trials, including candidates against Lyme disease, Shigella, and Zika.

Valneva is a global company with operations in Austria, Canada, France, Sweden, the United Kingdom, and the United States. They have a robust commercial portfolio and a strong commitment to ethical business practices, diversity, and environmental responsibility. Valneva emphasizes a culture of collaboration and respect, providing opportunities for employee growth and development. The company's success stems from the dedication and expertise of their diverse team, along with their innovative approach to vaccine research and development.

Valneva prioritizes work-life balance and offers flexible work arrangements to its employees. The company recognizes the importance of a diverse workforce and strives to create a supportive and inclusive environment. It encourages personal growth and development within a multicultural setting, emphasizing collaboration and a clear commitment to ethics, compliance, and integrity. While specific details regarding flexible work options are not explicitly mentioned, the emphasis on employee well-being and diversity suggests that Valneva may offer flexible work arrangements such as remote work opportunities, flexible hours, or other arrangements to accommodate employee needs.

Valneva offers a comprehensive benefits package designed to support its employees' well-being and professional development. The company provides stock options, an employee assistance program, gym membership or fitness allowance, and access to LinkedIn Learning. These benefits reflect Valneva's commitment to its employees' financial security, mental health, physical well-being, and professional growth.

Valneva is a specialty vaccine company dedicated to developing, manufacturing, and commercializing prophylactic vaccines for infectious diseases with significant unmet medical needs. Their mission is to contribute to a world where no one dies or suffers from a vaccine-preventable disease, with a focus on innovative and pioneering science to address potential vaccine-preventable diseases.

Valneva fosters a culture of respect, dedication, and motivation, emphasizing collaboration, ethical conduct, and long-term growth. They promote a multicultural environment where diverse perspectives are valued, and employees are encouraged to develop professionally while maintaining a work-life balance. The company values open and constructive dialogue amongst colleagues, and encourages their employees to engage in social engagement at the local level.

Valneva champions diversity, equity, and inclusion, recognizing that a diverse workforce is a strong asset. The company actively seeks to create a welcoming, open, and friendly work environment where employees of various nationalities and backgrounds can thrive. Valneva invests in employee development, offering training opportunities and encouraging work-life balance to ensure a supportive and inclusive culture.